Correlation of serum high-sensitivity C-reactive protein and interleukin-6 in patients with acute coronary syndrome

X H Wang1, S Q Liu2, Y L Wang2

  • 1Department of Cardiology, Liaocheng People's Hospital, Liaocheng, Shandong, China xiaohuawangcn@163.com.

Insights

Serum high-sensitivity C-reactive protein (hs-CRP) and Interleukin-6 (IL-6) are elevated in acute coronary syndrome (ACS). These inflammatory markers correlate positively, aiding in assessing plaque stability and ACS prognosis.

Area of Science:

  • Cardiology
  • Biochemistry
  • Inflammation Research

Background:

  • Serum high-sensitivity C-reactive protein (hs-CRP) indicates inflammation and plaque formation.
  • Interleukin-6 (IL-6) is an inflammatory marker linked to atherosclerosis and plaque rupture.
  • Understanding the relationship between hs-CRP and IL-6 in acute coronary syndrome (ACS) is crucial.

Purpose of the Study:

  • To investigate the correlation between hs-CRP and IL-6 levels in patients with ACS.
  • To evaluate the diagnostic and prognostic value of these markers in ACS.

Main Methods:

  • Study included 60 ACS patients (33 acute myocardial infarction, 27 unstable angina pectoris), 45 stable angina pectoris patients, and 45 healthy controls.
  • Serum hs-CRP was measured using immune turbidimetric method.
  • Serum IL-6 levels were determined by enzyme-linked immunosorbent assay (ELISA).

Main Results:

  • hs-CRP and IL-6 concentrations were significantly higher in acute myocardial infarction (AMI) and unstable angina pectoris (UAP) groups compared to stable angina pectoris (SAP) and healthy groups (P<0.01).
  • AMI group showed significantly higher levels than the UAP group (P<0.05).
  • A strong positive correlation (r=0.836) was observed between serum hs-CRP and IL-6 levels in ACS patients.

Conclusions:

  • Elevated hs-CRP and IL-6 levels are associated with ACS.
  • These inflammatory markers can help determine plaque stability and have prognostic relevance in ACS.
  • hs-CRP and IL-6 show significant value in the judgment of ACS prognosis.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
750
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
493
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.0K
Acute Inflammation II: Local and Systemic Effects01:25

Acute Inflammation II: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
45
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
919